The 18th Annual Scientific Conference of the Society on NeuroImmune Pharmacology
- First Online:
- Cite this article as:
- Chang, S.L. & Cabral, G.A. J Neuroimmune Pharmacol (2012) 7(Suppl 1): 1. doi:10.1007/s11481-012-9348-1
- 78 Downloads
The 18th Annual Conference of the Society on Neuroimmune Pharmacology (SNIP) will be held at the Hawaii Prince Hotel Waikiki in Honolulu, Hawaii from April 25–28, 2012. The conference will focus on defining the role of substances of abuse in modulating neuroimmune processes and determining the physiological and behavioral consequences of such alterations in infectious diseases, with HIV infection as the prime model. This focus will include basic and clinical neuroscience, neuroAIDS, and other neurodegenerative processes, as well as the behavioral sciences. The conference also will address the relationship between substances of abuse and HIV/AIDS, particularly with regard to etiology, genetics, epidemiology, prevention, treatment, health services, and therapeutic developments. A major goal of the conference and SNIP is to promote the professional development of young investigators. Thus, four events will be dedicated to young investigators. In addition, the Asian American Pacific Islander (AAPI) workgroup of the NIDA Special Population Office has collaborated with the Society to sponsor Early Career Investigators who will present their research. An exciting and comprehensive program has been assembled that brings together scientists and practitioners from around the world providing a platform for them to share their research and discuss the translational clinical and epidemiological relevance of this research to the community at large.